{"id":787291,"date":"2023-10-02T07:37:56","date_gmt":"2023-10-02T11:37:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-joins-the-national-alliance-on-mental-illness-and-others-advocating-for-the-importance-of-mental-health-on-mental-illness-awareness-week\/"},"modified":"2023-10-02T07:37:56","modified_gmt":"2023-10-02T11:37:56","slug":"axsome-therapeutics-joins-the-national-alliance-on-mental-illness-and-others-advocating-for-the-importance-of-mental-health-on-mental-illness-awareness-week","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/axsome-therapeutics-joins-the-national-alliance-on-mental-illness-and-others-advocating-for-the-importance-of-mental-health-on-mental-illness-awareness-week\/","title":{"rendered":"Axsome Therapeutics Joins the National Alliance on Mental Illness and Others Advocating for the Importance of Mental Health on Mental Illness Awareness Week"},"content":{"rendered":"
\n

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it is joining patient advocacy organizations, including the National Alliance on Mental Illness (NAMI), to promote awareness of the importance of mental health during Mental Illness Awareness Week (MIAW), recognized on Oct. 1-7, 2023.<\/p>\n

As part of Axsome\u2019s commitment to developing innovative therapies that make an impact on the lives of people suffering from CNS disorders including mental health conditions, Axsome supports and recognizes events such as MIAW to come together with other mental health advocates to amplify positive messages, share resources, and help raise awareness.<\/p>\n

NAMI\u2019s theme for MIAW 2023 is \u201cTogether We Care. Together We Share,\u201d chosen to convey \u201cthe power of coming together in community, which can be healing as people gather to share their experiences,\u201d as well as promote the impact that support and resources can have for those in need. To learn more about NAMI\u2019s efforts and plans for MIAW on their website, please check here<\/a>.<\/p>\n

In support of MIAW, Axsome is sponsoring NAMI\u2019s \u201cInspiring Hope Through Research\u201d event in Washington D.C. on Oct. 11. As part of NAMI\u2019s commitment to research, each year at this event NAMI gives an award to a researcher who moves the scientific understanding and treatment of mental illness forward. This year\u2019s awardee, Sabine Wilhelm, Ph.D., has been advancing the use of technology, such as smartphone-based treatments, to help people with mental health problems. You can learn more about Dr. Wilhelm here<\/a>.<\/p>\n

Each year one out of every five adults in the U.S. experience mental illness and, of those, approximately 40% (21 million) had a major depressive episode, characterized by at least one period of two weeks or longer when for most of the day nearly every day, they felt depressed or lost interest or pleasure in daily activities.1<\/sup> Additionally, only 47.2% of U.S. adults that experienced a mental illness in 2021 received treatment.2<\/sup> These figures highlight the high prevalence and serious impact of depression and other mental illness on people in the United States, and the need for improved access to treatment.<\/p>\n

The following organizations and their affiliates provide information about mental health, support networks for those directly affected and their families, as well as additional resources:<\/p>\n